These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21806373)

  • 21. Bridging the gap: bitopic ligands of G-protein-coupled receptors.
    Lane JR; Sexton PM; Christopoulos A
    Trends Pharmacol Sci; 2013 Jan; 34(1):59-66. PubMed ID: 23177916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenges in the development of heteromer-GPCR-based drugs.
    Franco R; Martínez-Pinilla E; Ricobaraza A; McCormick PJ
    Prog Mol Biol Transl Sci; 2013; 117():143-62. PubMed ID: 23663968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. G protein-coupled receptors as promising cancer targets.
    Liu Y; An S; Ward R; Yang Y; Guo XX; Li W; Xu TR
    Cancer Lett; 2016 Jul; 376(2):226-39. PubMed ID: 27000991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When simple agonism is not enough: emerging modalities of GPCR ligands.
    Smith NJ; Bennett KA; Milligan G
    Mol Cell Endocrinol; 2011 Jan; 331(2):241-7. PubMed ID: 20654693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamics and flexibility of G-protein-coupled receptor conformations and their relevance to drug design.
    Vaidehi N
    Drug Discov Today; 2010 Nov; 15(21-22):951-7. PubMed ID: 20831898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preface. G Protein-Coupled Receptors in Drug Discovery.
    Filizola M
    Methods Mol Biol; 2015; 1335():v. PubMed ID: 26478939
    [No Abstract]   [Full Text] [Related]  

  • 27. Cell-based assays in GPCR drug discovery. In this issue.
    Biotechnol J; 2008 Apr; 3(4):430. PubMed ID: 18412181
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular dynamics techniques for modeling G protein-coupled receptors.
    McRobb FM; Negri A; Beuming T; Sherman W
    Curr Opin Pharmacol; 2016 Oct; 30():69-75. PubMed ID: 27490828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. G-protein-coupled receptor type A heteromers as an emerging therapeutic target.
    Guidolin D; Agnati LF; Marcoli M; Borroto-Escuela DO; Fuxe K
    Expert Opin Ther Targets; 2015 Feb; 19(2):265-83. PubMed ID: 25381716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional selectivity and dualsteric/bitopic GPCR targeting.
    Schrage R; Kostenis E
    Curr Opin Pharmacol; 2017 Feb; 32():85-90. PubMed ID: 28027487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analyzing biased responses of GPCR ligands.
    Benredjem B; Dallaire P; Pineyro G
    Curr Opin Pharmacol; 2017 Feb; 32():71-76. PubMed ID: 27930943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of heteromerization to G protein-coupled receptor function.
    Gaitonde SA; González-Maeso J
    Curr Opin Pharmacol; 2017 Feb; 32():23-31. PubMed ID: 27835800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a cyclic adenosine monophosphate assay for Gi-coupled G protein-coupled receptors by utilizing the endogenous calcitonin activity in Chinese hamster ovary cells.
    Wang Y; Kong Y; Shei GJ; Kang L; Cvijic ME
    Assay Drug Dev Technol; 2011 Oct; 9(5):522-31. PubMed ID: 21561374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of GPCRs in neurodegenerative diseases: avenues for therapeutic intervention.
    Huang Y; Todd N; Thathiah A
    Curr Opin Pharmacol; 2017 Feb; 32():96-110. PubMed ID: 28288370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A-kinase anchoring proteins: trafficking in G-protein-coupled receptors and the proteins that regulate receptor biology.
    Malbon CC
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):573-9. PubMed ID: 17786856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The structure and dynamics of GPCR oligomers: a new focus in models of cell-signaling mechanisms and drug design.
    Filizola M; Weinstein H
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):577-84. PubMed ID: 16159019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug targets discovery based on dynamic signal transduction networks].
    Wang J; Li XJ
    Yao Xue Xue Bao; 2010 Jan; 45(1):1-8. PubMed ID: 21351442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional assays for screening GPCR targets.
    Thomsen W; Frazer J; Unett D
    Curr Opin Biotechnol; 2005 Dec; 16(6):655-65. PubMed ID: 16257523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of conformationally thermostabilised GPCRs in drug discovery: application to fragment, structure and biophysical techniques.
    Tehan BG; Christopher JA
    Curr Opin Pharmacol; 2016 Oct; 30():8-13. PubMed ID: 27400445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.